Center of Integrated Biomedical and Bioengineering Research

Center of Integrated Biomedical and Bioengineering Research
CIBBR
 
National Institutes of Health Phase 2, $10M award will accelerate innovative human health research at UNH.
 

Committed to the idea that truly valuable, paradigm-shifting research is often conducted in the space between research disciplines and across academic units and establishing UNH as a Center of Biomedical Research Excellence (COBRE):

  • Increasing the number of NIH-funded research project grants awarded to UNH faculty
  • Accelerating hiring and advancement of biomedical and bioengineering researchers
  • Acquiring state-of-the-art instrumentation in well-managed core facilities
  • Encouraging clinical research, commercial opportunities, and translational medicine
Center of Integrated Biomedical and Bioengineering Research

UNH's Center of Integrated Biomedical and Bioengineering Research Receives $10M NIH Grant

UNH's Center of Integrated Biomedical and Bioengineering Research Receives $10M NIH Grant

National Institutes of Health Phase 2 award will accelerate innovative human health research at UNH...

ARTICLE

 

CIBBR News

CIBBR News

kingsbury_hall

Two Professors Receive $4 million to Improve Wound Healing and Tissue Generation

Two Professors Receive $4 million to Improve Wound Healing and Tissue Generation

In a significant boost to biomedical research and ultimately human health outcomes...

ARTICLE

Carlota Dao in the lab

Dedicated to Health Disparities Research

Dedicated to Health Disparities Research

Nutrition researcher named a faculty fellow in a National Heart, Lung, and Blood Institute funded...

ARTICLE

Harish Vashisth

Repurposing Drug Compound Could Slow COVID Spread

Repurposing Drug Compound Could Slow COVID Spread

Acts to inhibit “molecular scissors” that lets virus replicate...

ARTICLE

Funded by a five-year, $10 million National Institutes of Health (NIH) grant, the UNH CIBBR strives to bridge the gap between basic biomedical and bioengineering research and clinical and/or commercial outcomes.  This COBRE is supported by the National Institute of General Medical Sciences, under Award Number P20GM113131.